IHT Begins Selling Opko's Protein Biomarker Prostate Cancer Dx
October 05, 2012
IHT Begins Selling Opko's Protein Biomarker Prostate Cancer Dx
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Opko to Purchase OURLab CLIA Lab to Support US Launch of 4Kscore Prostate Cancer Dx
October 26, 2012 / ProteoMonitor - Opko Licenses Protein Biomarker Panel for Prostate Cancer to IHT
May 4, 2012 / GenomeWeb Daily News - Opko Expands Prostate Cancer Biomarker Licensing Deal as Part of Commercialization Plan
March 23, 2012 / ProteoMonitor - Opko Licenses Kallikrein Proteins as Biomarkers for Prostate Cancer
January 30, 2012 / ProteoMonitor - Opko Acquires Brazilian Pharma Company, Clearing Way for Launch of 4kscore Prostate Cancer Test
February 22, 2013 / ProteoMonitor